DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 9.29 0.23%
S&P 500 1,864.85 2.54 0.14%
market minute promo

Omeros

NASDAQ: OMER

11.27 -0.06 (-0.53%)

REAL-TIME: Last trade at

Extended Hours: $11.27 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

OMER $11.27 -0.53%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $11.25
Previous Close $11.33
Daily Range $11.02 - $11.62
52-Week Range $3.65 - $14.69
Market Cap $376.5M
P/E Ratio -8.15
Dividend (Yield) $0.00 (0.0%)
Volume 356,553
Average Daily Volume 503,400
Current FY EPS -$1.47

Sector

Healthcare

Industry

Drugs

Omeros (OMER) Description

Omeros Corporation is a clinical-stage Biopharmaceutical Company engaged in discovering developing and commercializing products focused on inflammation and disorders of the central nervous system. Website: http://www.omeros.com/

News & Commentary

3 Under-the-Radar Biotech Stocks You Need to Watch in 2014

Nektar Therapeutics, Omeros, and Spectrum Pharmaceuticals all face off with regulators in key decision dates for their developmental drugs later this year

Will St. Jude Medical (STJ) Surprise This Earnings Season? - Analyst Blog

Sector Update: Healthcare Shares Mixed Pre-Market; Vivus Sinks 5% on Piper Jaffray Downgrade

Sector Update: Healthcares

US Stock Futures Edge Higher Ahead Of Jobless Claims Data

Omeros Announces Proposed Public Offering of Common Stock

Additional Positive Data on Omeros Treatment - Analyst Blog

Sector Update: Healthcare Shares Higher Pre-Market; Omeros Gains 5% on Positive Results From Schizop

Sector Update: Healthcare Shares Higher Pre-Market; Omeros Gains 5% on Positive Results From Schizophrenia Treatment Trial

Sector Update: Healthcare

Cramer's Lightning Round - No Growth In Fertilizer (2/24/14)

'Mad Money' Lightning Round: World Wrestling Is a Turnaround Play

See More OMER News...

OMER's Top Competitors

OMER $11.27 (-0.53%)
Current stock: OMER
AMGN $115.46 (-0.07%)
Current stock: AMGN
GILD $70.00 (1.04%)
Current stock: GILD
BIIB $290.54 (-0.32%)
Current stock: BIIB